
Transplant Hepatologist/Assistant Professor - University of Florida @UFHepGastro
Gainesville, FL
Joined August 2018
- Tweets93
- Following158
- Followers81
- Likes12
Nimy John retweeted
Unexpected opening for a PGY1 Internal Medicine Categorical position with Saint Vincent Hospital, Worcester, Massachusetts.
Reach out via email with a full application to the Program Administrator: Tina.Kachadoorian@stvincenthospital.com
Nimy John retweeted
Great review on perioperative managent of DOAC treated patients by Dr Douketis and @AlexSpyropoul from JAMA
Narrative review explores how to manage use of DOACs—apixaban, rivaroxaban, edoxaban, and dabigatran—in patients undergoing surgical and nonsurgical procedures to decrease risks of bleeding and thromboembolism. ja.ma/4fIm1hL
Nimy John retweeted
HRS-HARMONY in @LTxJournal: AKI treatment (& ⬇️ MELD) in pts w/ cirrhosis a/w delayed & ⬇️ rate of txp but ⬆️ survival. For all listed comers w/ moderate duration f/u, AKI reversal & delayed txp may be favorable over persistent/progressive AKI @jmbnephdoc
journals.lww.com/lt/abstract…
Nimy John retweeted
An estimated 15 million Americans take supplements that may be toxic to their livers according to a new @umichmedicine study in @JAMANetworkOpen michiganmedicine.org/health-…
Nimy John retweeted
ORIGINAL ARTICLE
Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease
Shang et al.
#LiverX
tinyurl.com/yc2nj9mr
Nimy John retweeted
A tale of two diseases: ALD and MASLD requirements and monitoring for LT! @drbobbybrown journals.lww.com/lt/abstract…
Nimy John retweeted
Salt of the earth: Predicting and treating alcohol relapse in high risk patients by Drs. Sengupta and Mellinger! journals.lww.com/lt/abstract…
Nimy John retweeted
⭐️Today marks the launch of the EASL SLD Summit 2025, taking place on 23-25 January 2025 in Estoril, Portugal! You can now check the scientific programme, submit your abstract, and secure your spot.
Celebrate 20 years of advancements in Steatotic Liver Disease (SLD) with us. Discover the latest in MASLD, MetALD, and ALD, and contribute to shaping the future of hepatology.
🗓️ Important Dates:
Abstract Submission: 29 October 2024
Early Registration fee deadline: 31 October 2024
We look forward to seeing you in Estoril and online!
👉easl.eu/event/easl-sld-summi…
***
#Livertwitter @AleksanderKrag @DebbieShawcros1 @FrancqueSven @aelsharkawy75 @fprusso73 @analleo @SagiZelber @bogdanprocopet @RuiCastroHD
Nimy John retweeted
Modulating immunosuppression to reduce cardiovascular risk? YEESSSS
Check out this review by @kymwatt et al.
journals.lww.com/transplantj…
Nimy John retweeted
Analyses of Continuous Glucose Monitor data from 8000+ "healthy adults" offers many insights.
~40% who had a morning fasting glucose in "normal range" turned out to be prediabetic and 3% were diabetic. Wearing a CGM once a year is worth it.
nature.com/articles/s41591-0…
Nimy John retweeted
Another great paper from the @ascrs Pelvic floor consortium group👏🏻👏🏻@LilianaBordei @BrookeGurland @annaspivs Craig Olson, Anders Mellgren
Nimy John retweeted
Four years of work- Key paper to read
Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA gut.bmj.com/content/early/20… @AASLDtweets @EASLnews @INASL_Liver @DrHuangDQ @f_tavaglione @UCSD_GI
Nimy John retweeted
Hello, real doctor here, and not some ill-informed staff writer for the @TheAtlantic trying to put public health in danger.
Educate yourself.
No amount of alcohol is safe for human health.
who.int/europe/news/item/04-…
It is not about "mortality" which has multiple other confounding factors but the realistic danger of developing avoidable cancers, which can happen with even less than one drink a day. Wine is alcohol too. A small glass of red wine (100 ml or 3.4 fluid ounces) has 13% alcohol by volume.
newsroom.uw.edu/news-release…
Alcohol consumption was linked to more than 740,000 new cancer cases in 2020.
thelancet.com/infographics-d…
Studies that showed "benefits" of alcohol were all "made up." Research exposes flaws of older, often industry-funded studies and finds lowest mortality risk in lifelong abstainers.
Scientific support for alcohol’s "health benefits" is fading. Read here.
theguardian.com/society/arti…
Why Do Only Some Cohort Studies Find Health Benefits From Low-Volume Alcohol Use? A Systematic Review and Meta-Analysis of Study Characteristics That May Bias Mortality Risk Estimates
pubmed.ncbi.nlm.nih.gov/3828…
Listen to those who care about your health. Like doctors. Not journalists or podcasters.
Nimy John retweeted
Been saying this for a very long time. Still time for all you supplement lovers to throw these toxic ones out and save on money and hospital visits. Do not trust supplement promoters on social media, doctors included.
newatlas.com/medical/turmeri…
Nimy John retweeted
Basiliximab induction and monotherapy with tacrolimus reduced the incidence of acute cellular rejection and an improved ACR-free survival rate at 2 y compared with the control group. #TXPJournal #TXPForAll tinyurl.com/ycxuw3bk
Nimy John retweeted
Dr. Mindie Nguyen, a CARE faculty member, has published a paper titled “Sex and Ethnic Disparities in Hepatitis B Evaluation and Treatment Across the World.” They found that disparities exist in hepatitis B evaluation and treatment. Read it here: sciencedirect.com/science/ar…
Nimy John retweeted
🙌 Congrats to @LinChangMD (#UCLAGI) on your nomination for your work on the Joint Guidelines for Chronic Constipation!
🩺Our Clinical Innovation noms push like Olympians to better GI! Help @AmCollegeGastro and @GoHealio decide who takes home🏅
@LinChangMD
Brian Lacy MD @MayoClinicFLGIH
Alberto Rubio-Tapia MD @ClevelandClinic
Scott Tenner MD @SUNY
@singal_ashwani
🗳️bit.ly/3Sx9tjv
Nimy John retweeted
Early LDLT for AH. Considerations, ethical challenges and unmet needs. @LTxJournal @_LTSI_ @rabataller @MarcoArreseMD @juanpabloarab @DeepikaDevuniMD #livertwitter #transplanttwitter journals.lww.com/lt/abstract…
































